Publications
Wong SQ, Ouellette A, Harrison L, McNamara A, Tam RA, Alexandrov A, Nawrocik-Madrid A, Sanchez JJ, Ginsburg BC, Andrade AA, Lapierre LR. Spatial memory in Alzheimer’s disease 5XFAD mice is enhanced by XPO1 inhibitor KPT-330. Geroscience. 2026 Feb 6. doi: 10.1007/s11357-026-02122-0. Epub ahead of print. PMID: 41652154.
Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer’s-like pathology
Jayarathne H, Manchanayake DH, Chimienti N, Kadri O, Gurdziel K, Kim S, Jang H, Ginsburg BC, Miller RA, Yakar S, Sadagurski M. Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer’s-like pathology. bioRxiv [Preprint]. 2025 Jun 15:2025.06.10.658747. doi: 10.1101/2025.06.10.658747. PMID: 40661442; PMCID: PMC12259070.
One month follow-up outcomes of a transdermal alcohol concentration-based contingency management intervention to reduce heavy drinking among driving while intoxicated arrestees
Hill-Kapturczak N, Lamb RJ, Roache JD, Moon TJ, Liang Y, Dougherty DM. One month follow-up outcomes of a transdermal alcohol concentration-based contingency management intervention to reduce heavy drinking among driving while intoxicated arrestees. Alcohol Clin Exp Res (Hoboken). 2025 May;49(5):1166-1176. doi: 10.1111/acer.70047. Epub 2025 Mar 31. PMID: 40165510; PMCID: PMC12097931.
Calibration and evaluation of a refined pharmacokinetic model for three homologs of phosphatidylethanol
Simon TW, Ginsburg B, Javors MA, Hill-Kapturczak N, Lopez-Crusan M, Stark H, Dougherty DM, Roache JD. Calibration and evaluation of a refined pharmacokinetic model for three homologs of phosphatidylethanol. Chem Biol Interact. 2025 Feb 25;408:111414. doi: 10.1016/j.cbi.2025.111414. Epub 2025 Feb 6. PMID: 39914503.
